Eledon Pharmaceuticals Inc <ELDN.OQ> expected to post a loss of 26 cents a share - Earnings Preview
Eledon Pharmaceuticals Inc ELDN.OQ ELDN.O is expected to show no change in quarterly revenue when it reports results on November 10 (estimated) for the period ending September 30 2025
LSEG's mean analyst estimate for Eledon Pharmaceuticals Inc is for a loss of 26 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts had risen by about 5.5% in the last three months.
Wall Street's median 12-month price target for Eledon Pharmaceuticals Inc is $9.00, about 71.1% above its last closing price of $2.60
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Jun. 30 2025 | -0.20 | -0.23 | -0.13 | Beat | 43.5 |
Mar. 31 2025 | -0.30 | -0.30 | -0.08 | Beat | 73.6 |
Dec. 31 2024 | -0.31 | -0.32 | 0.67 | Beat | 310.7 |
Sep. 30 2024 | -0.20 | -0.31 | -0.32 | Missed | -1.6 |
Jun. 30 2024 | -0.29 | -0.30 | -1.06 | Missed | -249.4 |
Mar. 31 2024 | -0.36 | -0.37 | -0.34 | Beat | 7 |
Dec. 31 2023 | -0.39 | -0.29 | Beat | 26 | |
Sep. 30 2023 | -0.50 | -0.46 | -0.35 | Beat | 24 |
This summary was machine generated August 15 at 20:29 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Related Articles
Costco FY2025 Q4 Earnings Preview: Decoding Growth Drivers and Market Bets Amid Sky-High Valuation
TradingKey - Since the release of Costco's fiscal 2025 third-quarter earnings report, its stock performance has slightly underperformed the S&P 500 index. After a significant year-to-date rally, the stock has entered a consolidation phase, exhibiting a contracting triangle pattern, reflecting...
Zeta Global (ZETA): Solid Data Moat Can Drive Value Up
TradingKey - Simply speaking, Zeta is a marketing tech company that leverages its high-quality, proprietary data and AI tools to automate a wide range of marketing tasks, helping marketers and brands conduct campaigns on various channels. The company’s solid moat is based on its high-quality...-8fe429c75f0a48aa94f43d6c5c639094.jpg)
Fed Rate Cuts: Will the Russell 2000 Outperform the S&P 500?
TradingKey - On 17 September, the Federal Reserve cut interest rates by 25 basis points, marking the official restart of the rate-cutting cycle. In theory, small-cap stocks, compared to large-cap stocks, benefit more from Fed rate cuts. This is because they are more reliant on external financing...
Uranium Energy Corp. (UEC) Earnings Preview: Is there any Uranium out there?
TradingKey - Uranium Energy Corp (UEC) will report fourth-quarter and full-year earnings on the 24th of September, before the opening bell. The company’s stock price has been performing very strongly, being up 61% on a year-to-date basis - a rally closely related to uranium as a commodity._croped_889x500 (1)-666c3deec8f74a1d91bccfc0edb42909.jpg)
AI’s Next Battlefield: Broadcom’s TPU-Backed ASICs Challenge Nvidia’s GPU Dominance
TradingKey - Broadcom (NASDAQ: AVGO) recently secured a landmark $10 billion deal with OpenAI to supply custom AI accelerators, solidifying its leadership in the booming AI semiconductor market. Alongside its longstanding Google TPU partnership, this positions Broadcom to capture significant growth.jpg)
